The aim of this conference is to convene experts in the field of cerebral amyloid angiopathy and hear about the latest developments in CAA research ranging from basic research to studies in humans. Amongst others, the conference will include presentations on genetics, epidemiology, neuropathology, neuroimaging, clinical trials, and experimental animal research. Traditionally, this event provides a unique opportunity to meet with leading scientists in the field of CAA and related areas, including neuroscience, cardiovascular medicine, and methods development and enable investigators at all career stages to establish connections, start collaborations and generate new ideas.
This ICAA conference will cover key topics in CAA research such as immune-mechanisms, interactions with neurodegenerative disease, mechanisms at the BBB and of intracrebral hemorrhage, high frequency imaging, ARIA, amyloid transmission, risk prediction, treatment approaches, brain waste clearance, and results from omics studies. The program includes a diverse range of invited speakers as well as speakers selected from submitted abstracts, who will present highly topical and unpublished research. The format prioritizes discussion and informal interactions among scientists of all career levels.
Participation into the conference, which will be in a wonderful location next to the famous English Garden, requires registration via this website. Please visit this website to learn about updates.
We look forward to welcoming you all at the conference in this truly exciting time for CAA research!